Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanborn

Showing results (921-930 of 996) with videos related to

Pageof 100
Sort By:
Cancer Research Communications|January 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid TumorsJong Chul Park, David Berz, Manish R Sharma, et al.
The American Journal of Tropical Medicine and Hygiene|October 8, 2024
Electronic Clinical Decision Support Tools: Strategies to Improve the Management of Lower Respiratory Tract Infections in Low-Resource SettingsL Gayani Tillekeratne, Warsha De Soyza, Maria D Iglesias-Ussel, et al.
Cancer Research Communications|February 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid TumorsJong Chul Park, David Berz, Manish R Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung CancerSolange Peters, Sarina A Piha-Paul, Kartik Sehgal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2025
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung CancerMelissa L Johnson, Egbert F Smit, Enriqueta Felip, et al.
The Lancet. Microbe|February 15, 2025
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled studyMelinda J Hamer, James M McCarty, Benjamin C Pierson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 28, 2023
A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern AfricaKatherine Van Loon, Elia J Mmbaga, Beatrice P Mushi, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Cancer Research|November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patientsBrendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 5, 2024
Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed TomographyWilliam A Zoghbi, Pei-Ni Jone, Mohammed A Chamsi-Pasha, et al.
Pageof 100

Showing results (921-930 of 996) with videos related to

Sort By:
Pageof 100
Cancer Research Communications|January 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid TumorsJong Chul Park, David Berz, Manish R Sharma, et al.
The American Journal of Tropical Medicine and Hygiene|October 8, 2024
Electronic Clinical Decision Support Tools: Strategies to Improve the Management of Lower Respiratory Tract Infections in Low-Resource SettingsL Gayani Tillekeratne, Warsha De Soyza, Maria D Iglesias-Ussel, et al.
Cancer Research Communications|February 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid TumorsJong Chul Park, David Berz, Manish R Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung CancerSolange Peters, Sarina A Piha-Paul, Kartik Sehgal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2025
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung CancerMelissa L Johnson, Egbert F Smit, Enriqueta Felip, et al.
The Lancet. Microbe|February 15, 2025
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled studyMelinda J Hamer, James M McCarty, Benjamin C Pierson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 28, 2023
A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern AfricaKatherine Van Loon, Elia J Mmbaga, Beatrice P Mushi, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Cancer Research|November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patientsBrendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 5, 2024
Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed TomographyWilliam A Zoghbi, Pei-Ni Jone, Mohammed A Chamsi-Pasha, et al.
Pageof 100